Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

396.61
Delayed Data
As of Feb 05
 -15.98 / -3.87%
Today’s Change
392.35
Today|||52-Week Range
605.93
-26.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
AssetsCash648.7M507.9M390.6M654.6M
 
 
 
 
 
Short Term Investment Cash2.2M-140.8M-117.4M264.0M
 
 
 
 
 
Cash & Short Term Investments900.5M742.2M604.2M895.6M
 
 
 
 
 
 
ReceivablesReceivables1.0B1.3B1.4B1.4B
 
 
 
 
 
 
InventoriesInventories128.9M133.9M171.3M190.7M
 
 
 
 
 
 
Current AssetsOther Current Assets120.7M96.2M112.7M150.0M
 
 
 
 
 
Current Assets2.2B2.3B2.3B2.7B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.2B1.1B1.3B1.5B
 
 
 
 
 
Depreciation-254.0M------
 
 
Other Assets3.0M4.5M4.1M4.6M
 
 
 
 
 
Total Assets3.9B4.2B4.5B5.2B
 
 
 
 
 
 
LiabilitiesAccounts Payable99.5M90.6M130.0M106.9M
 
 
 
 
 
Accrued Expenses291.9M308.0M316.4M349.6M
 
 
 
 
 
Other Current Liabilities462.4M381.4M388.4M507.1M
 
 
 
 
 
Other Liabilities654.7M536.1M601.5M735.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt457.7M472.5M388.0M394.9M
 
 
 
 
 
Deferred Taxes-266.9M-289.5M-323.8M-346.2M
 
 
 
 
 
Other Liabilities40.9M55.6M76.1M77.9M
 
 
 
 
 
Total Liabilities1.3B1.2B1.2B1.9B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity2.5B3.0B3.3B3.3B
 
 
 
 
 
Total Shareholder Equity2.5B3.0B3.3B3.3B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding102.4M103.2M103.6M104.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.